Active Motif Incorporated Licenses Targeted Transposition to Diagenode S.A. Technology ...Middle East

PR Newswire - News
CARLSBAD, Calif., July 31, 2022 /PRNewswire/ -- Active Motif Incorporated, a company with the vision of bringing epigenetics more deeply into precision medicine, announced that it has non-exclusively licensed its foundational patents in transposition for use in CUT&Tag epigenetic assays...

Hence then, the article about active motif incorporated licenses targeted transposition to diagenode s a technology was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Active Motif Incorporated Licenses Targeted Transposition to Diagenode S.A. Technology )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News